Cortisol is negatively associated with insulin sensitivity in overweight Latino youth

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4729-4735

  Adam, Tanja C ^a   Hasson, Rebecca E ^a   Ventura, Emily E ^a   Toledo Corral, Claudia ^a   Le, Kim Ann ^a   Mahurkar, Swapna ^a   Lane, Christianne J ^a   Weigensberg, Marc J ^a   Goran, Michael I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROCORTISONE; INSULIN;

ADOLESCENT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RISK; SCHOOL CHILD;

EID: 77957819636     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0322     Document Type: Article

References (39)

1. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF 2003 Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884-1890
2. Goran MI, Lane C, Toledo-Corral C, Weigensberg MJ 2008 Persistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor β-cell function and increasing visceral fat. Diabetes 57:3007-3012
3. Goran MI, Bergman RN, Cruz ML, Watanabe R 2002 Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 25:2184-2190
4. DeSantis AS, Adam EK, Doane LD, Mineka S, Zinbarg RE, Craske MG 2007 Racial/ethnic differences in cortisol diurnal rhythms in a community sample of adolescents. J Adolesc Health 41:3-13
5. Adam TC, Epel ES 2007 Stress, eating and the reward system. Physiol Behav 91:449-458
6. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M 1993 Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14:303-347
7. Rosmond R 2003 Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes? Med Sci Monit 9:RA35-RA39
8. Lambillotte C, Gilon P, Henquin JC 1997 Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99:414-423
9. Coderre L, Vallega GA, Pilch PF, Chipkin SR 1996 In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol 271:E643-E648
10. van Raalte DH, Ouwens DM, Diamant M 2009 Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 39:81-93
11. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte Jr D 1984 Dexamethasone-induced insulin resistance enhancesBcell responsiveness to glucose level in normal men. Am J Physiol 247:E592-E596
12. Grill V, Pigon J, Hartling SG, Binder C, Efendic S 1990 Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. Metabolism 39:251-258
13. Larsson H, Ahrén B 1999 Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity. Diabetologia 42:936-943
14. Björntorp P 1997 Neuroendocrine factors in obesity. J Endocrinol 155:193-195
15. Björntorp P, Rosmond R 2000 Obesity and cortisol. Nutrition 16:924-936
16. Turner RJ, Avison WR 2003 Status variations in stress exposure: implications for the interpretation of research on race, socioeconomic status, and gender. J Health Soc Behav 44:488-505
17. Weigensberg MJ, Toledo-Corral CM, Goran MI 2008 Association between the metabolic syndrome and serum cortisol in overweight Latino youth. J Clin Endocrinol Metab 93:1372-1378
18. Goran MI, Bergman RN, Avila Q, Watkins M, Ball GD, Shaibi GQ, Weigensberg MJ, Cruz ML 2004 Impaired glucose tolerance and reduced β-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 89:207-212
19. 1998 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 68:899-917
20. Tanner JM 1981 Growth and maturation during adolescence. Nutr Rev 39:43-55
21. 2000 Type 2 diabetes in children and adolescents. American Diabetes Association. Pediatrics 105:671-680
22. Bergman RN, Phillips LS, Cobelli C 1981 Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467
23. Amatruda JM, Livingston JN, Lockwood DH 1985 Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure. Diabetes Metab Rev 1:293-317
24. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al. 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
25. Overgaard D, Gyntelberg F, Heitmann BL 2004 Psychological workload and body weight: is there an association? A review of the literature. Occup Med (Lond) 54:35-41
26. Rosmond R, Dallman MF, Björntorp P 1998 Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853-1859
27. Rosmond R, Lapidus L, Björntorp P 1996 The influence of occupational and social factors on obesity and body fat distribution in middle-aged men. Int J Obes Relat Metab Disord 20:599-607
28. Björntorp P 1993 Visceral obesity: a "civilization syndrome." Obes Res 1:206-222
29. Vicennati V, Pasquali R 2000 Abnormalities of the hypothalamic-pituitary- adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab 85:4093-4098
30. Pasquali R, Vicennati V, Cacciari M, Pagotto U 2006 The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann NY Acad Sci 1083:111-128 (Pubitemid 44955469)
31. Dorn LD, Lucke JF, Loucks TL, Berga SL 2007 Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann Clin Biochem 44:281-284
32. Scacchi M, Pincelli AI, Cavagnini F 1999 Growth hormone in obesity. Int J Obes Relat Metab Disord 23:260-271
33. Misra M, Bredella MA, Tsai P, Mendes N, Miller KK, Klibanski A 2008 Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab 295: E385-E392
34. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ 2002 Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359:1740-1745
35. Kreitschmann-Andermahr I, Suarez P, Jennings R, Evers N, Brabant G 2010 GH/IGF-I regulation in obesity-mechanisms and practical consequences in children and adults. Horm Res Paediatr 73:153-160
36. Toledo-Corral CM, Roberts CK, Shaibi GQ, Lane CJ, Higgins PB, Davis JN, Weigensberg MJ, Goran MI 2008 Insulin-like growth factor-I is inversely related to adiposity in overweight Latino children. J Pediatr Endocrinol Metab 21:855-864
37. Ravaja N, Keltikangas-Järvinen L, Viikari J 1996 Life changes, locus of control and metabolic syndrome precursors in adolescents and young adults: a three-year follow-up. Soc Sci Med 43:51-61 (Pubitemid 26190870)
38. Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Ostenson CG, Gustafsson J, Efendic S, Okret S 1997 Pancreatic β cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 100:2094-2098
39. Pivonello R, Faggiano A, Lombardi G, Colao A 2005 The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am 34:327-339, viii